Niagen Bioscience (NAGE) News Today $9.86 -0.28 (-2.76%) As of 09/19/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAGE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period AboutNAD? Debuts as the Leading Online Resource for Scientific Advancements in NAD+September 16, 2025 | tmcnet.comAboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+September 16, 2025 | businesswire.comThree Growth Stocks With Strong Insider CommitmentSeptember 12, 2025 | finance.yahoo.comNiagen Bioscience (NASDAQ:NAGE) Lowered to Buy Rating by Wall Street ZenSeptember 10, 2025 | marketbeat.comNiagen Bioscience: A Great Company Suffering From Stock DilutionSeptember 8, 2025 | seekingalpha.comNiagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Buy" from AnalystsSeptember 3, 2025 | marketbeat.comNiagen Bioscience, Inc.'s (NASDAQ:NAGE) Intrinsic Value Is Potentially 91% Above Its Share PriceSeptember 2, 2025 | uk.finance.yahoo.comNiagen Bioscience (NASDAQ:NAGE) Upgraded to Strong-Buy at Wall Street ZenSeptember 2, 2025 | marketbeat.comNiagen Bioscience (NASDAQ:NAGE) Stock Rating Lowered by Wall Street ZenAugust 26, 2025 | marketbeat.comNiagen Bioscience, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 19, 2025 | seekingalpha.comUnlocking Cellular Health With Science and TrustAugust 17, 2025 | latimes.comNiagen Bioscience (NASDAQ:NAGE) Rating Increased to Strong-Buy at Wall Street ZenAugust 17, 2025 | marketbeat.comHC Wainwright Expects Reduced Earnings for Niagen BioscienceAugust 16, 2025 | marketbeat.comHC Wainwright Issues Optimistic Outlook for NAGE EarningsAugust 15, 2025 | marketbeat.comNiagen: Imminent Trigger For A Significant Move Up (Technical Analysis)August 13, 2025 | seekingalpha.comStatutory Profit Doesn't Reflect How Good Niagen Bioscience's (NASDAQ:NAGE) Earnings AreAugust 13, 2025 | finance.yahoo.comNiagen Bioscience (NASDAQ:NAGE) Given New $12.00 Price Target at HC WainwrightAugust 12, 2025 | marketbeat.comQ2 EPS Forecast for Niagen Bioscience Increased by AnalystAugust 12, 2025 | marketbeat.comBreaking Down Niagen Bioscience: 4 Analysts Share Their ViewsAugust 11, 2025 | benzinga.comRoth Capital Cuts Earnings Estimates for Niagen BioscienceAugust 9, 2025 | marketbeat.comEarnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsAugust 8, 2025 | finance.yahoo.comNiagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Strong EarningsAugust 8, 2025 | marketbeat.comNiagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of "Buy" by BrokeragesAugust 8, 2025 | marketbeat.comNiagen Bioscience Reports Strong Q2 Sales GrowthAugust 6, 2025 | msn.comNiagen Bioscience Inc (NAGE) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 6, 2025 | finance.yahoo.comNiagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year ...August 6, 2025 | gurufocus.comNiagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year OutlookAugust 6, 2025 | businesswire.comExamining the Future: Niagen Bioscience's Earnings OutlookAugust 5, 2025 | benzinga.comNiagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth ConferenceAugust 4, 2025 | finance.yahoo.comNiagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth ConferenceAugust 4, 2025 | businesswire.comNiagen Bioscience (NASDAQ:NAGE) Cut to "Buy" at Wall Street ZenAugust 3, 2025 | marketbeat.comNiagen Bioscience (NASDAQ:NAGE) Trading 6% Higher - What's Next?July 29, 2025 | marketbeat.comNiagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025July 23, 2025 | businesswire.comNiagen Bioscience (NASDAQ:NAGE) Shares Down 4% - Here's What HappenedJuly 18, 2025 | marketbeat.comNiagen Bioscience Inc. (NAGE) Stock Price Today - WSJJuly 18, 2025 | wsj.comRobert Fried Says Niagen Bioscience Has the Key to Better Aging, and He Has the Science to Prove ItJuly 16, 2025 | latimes.comNiagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Recommendation of "Buy" from AnalystsJuly 14, 2025 | marketbeat.comNiagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New YorkJuly 14, 2025 | theglobeandmail.comNiagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New YorkJuly 14, 2025 | businesswire.comNiagen Bioscience stock rises on exclusive Parkinson’s treatment licenseJuly 9, 2025 | in.investing.comNiagen Bioscience Shares Climb Following Exclusive License for Parkinson’s TherapyJuly 9, 2025 | msn.comNiagen Bioscience Secures Exclusive License to Develop and Commercialize its NAD+ Precursor, Patented Nicotinamide Riboside (Niagen®), as a Potential Parkinson's Disease Therapy in Agreement with Haukeland University Hospital in Bergen, NorwayJuly 8, 2025 | businesswire.comNAGE - Niagen Bioscience Inc Executives - MorningstarJuly 1, 2025 | morningstar.comMNiagen Bioscience (NASDAQ:NAGE) Stock Price Down 9.5% - Here's What HappenedJuly 1, 2025 | marketbeat.comEarnings Forecast & History for Niagen Bioscience Inc (NAGE) | Price ReactionsJuly 1, 2025 | investing.comNiagen Bioscience (NASDAQ:NAGE) Reaches New 1-Year High - What's Next?June 30, 2025 | marketbeat.com2NAGE : Breaking Update: Wendy Tak Wing YU Engages In Options Exercise At Niagen...June 27, 2025 | benzinga.com1NAGE : Engaging In Insider Activity, Kristin Patrick At Niagen Bioscience Exercises...June 27, 2025 | benzinga.comMajor Update: Frank Jaksch Jr At Niagen Bioscience Exercises Options, Realizing $0June 26, 2025 | benzinga.comOptions Exercise Update At Niagen Bioscience: Ann Cohen Engages, Resulting In $0June 26, 2025 | benzinga.com Get Niagen Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for NAGE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NAGE Media Mentions By Week NAGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAGE News Sentiment▼0.470.79▲Average Medical News Sentiment NAGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAGE Articles This Week▼23▲NAGE Articles Average Week Get the Latest News and Ratings for NAGE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Niagen Bioscience and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CNTA News Today NAMS News Today RARE News Today SRRK News Today VKTX News Today XENE News Today MOR News Today IMVT News Today HCM News Today KNSA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NAGE) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Niagen Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Niagen Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
